TY - JOUR
T1 - Direct measurements of blood glucose concentration in the presence of saccharide interferences using slope and bias orthogonal signal correction and Fourier transform near-infrared spectroscopy
AU - Abookasis, David
AU - Workman, Jerome J.
PY - 2011/2
Y1 - 2011/2
N2 - Saccharide interferences such as Dextran, Galactose, etc. have a great potential to interfere with near infrared (NIR) glucose analysis since they have a similar spectroscopic fingerprint and are present physiologically at large relative concentrations. These can lead to grossly inappropriate interpretation of patient glucose levels and resultant treatment in critical care and hospital settings. This study describes a methodology to reduce this effect on glucose analysis using an NIR Fourier transform spectroscopy method combined with a multivariate calibration technique (PLS) using preprocessing by orthogonal signal correction (OSC). A mathematical approach based on the use of a single calibration based bias and slope correction was applied in addition to a standard OSC was investigated. This approach is combined with a factorial interferent calibration design to accommodate for interference effects. We named this approach as a slope and bias OSC (sbOSC). sbOSC differs from OSC in the way it handles the prediction. In sbOSC, statistics on slope and bias obtained from a set of calibration samples are then used as a validation parameter in the prediction set. Healthy human volunteer blood with different glucose (80 to 200 mg/dL) and hematocrit (24 to 48 vol.%) levels containing high expected levels of inteferents have been measured with a transmittance near-infrared Fourier transform spectrometer operates in the broadband spectral range of 1.25-2.5 μm (4000-8000 cm -1). The effect of six interferents compounds used in intensive care and operating rooms, namely Dextran, Fructose, Galactose, Maltose, Mannitol, and Xylose, were tested on blood glucose. A maximum interference effect (MIE) parameter was used to rank the significance for the individual interferent type on measurement error relative to the total NIR whole blood glucose measurement error. For comparison, a YSI (Yellow Springs Instrument) laboratory reference glucose analyzer and NIR data were collected at the same time as paired samples. MIE results obtained bysbOSC were compared with several standard spectral preprocessing approaches and show a substantial reduced effect of saccharide interferences. NIR glucose measurement results are substantially improved when comparing standard error of prediction from validation samples; and resulting MIE values are small.
AB - Saccharide interferences such as Dextran, Galactose, etc. have a great potential to interfere with near infrared (NIR) glucose analysis since they have a similar spectroscopic fingerprint and are present physiologically at large relative concentrations. These can lead to grossly inappropriate interpretation of patient glucose levels and resultant treatment in critical care and hospital settings. This study describes a methodology to reduce this effect on glucose analysis using an NIR Fourier transform spectroscopy method combined with a multivariate calibration technique (PLS) using preprocessing by orthogonal signal correction (OSC). A mathematical approach based on the use of a single calibration based bias and slope correction was applied in addition to a standard OSC was investigated. This approach is combined with a factorial interferent calibration design to accommodate for interference effects. We named this approach as a slope and bias OSC (sbOSC). sbOSC differs from OSC in the way it handles the prediction. In sbOSC, statistics on slope and bias obtained from a set of calibration samples are then used as a validation parameter in the prediction set. Healthy human volunteer blood with different glucose (80 to 200 mg/dL) and hematocrit (24 to 48 vol.%) levels containing high expected levels of inteferents have been measured with a transmittance near-infrared Fourier transform spectrometer operates in the broadband spectral range of 1.25-2.5 μm (4000-8000 cm -1). The effect of six interferents compounds used in intensive care and operating rooms, namely Dextran, Fructose, Galactose, Maltose, Mannitol, and Xylose, were tested on blood glucose. A maximum interference effect (MIE) parameter was used to rank the significance for the individual interferent type on measurement error relative to the total NIR whole blood glucose measurement error. For comparison, a YSI (Yellow Springs Instrument) laboratory reference glucose analyzer and NIR data were collected at the same time as paired samples. MIE results obtained bysbOSC were compared with several standard spectral preprocessing approaches and show a substantial reduced effect of saccharide interferences. NIR glucose measurement results are substantially improved when comparing standard error of prediction from validation samples; and resulting MIE values are small.
KW - Blood glucose measurements
KW - Fourier transform infrared spectroscopy
KW - Maximum interference effect
KW - Orthogonal signal correction
KW - Saccharide interferents
UR - http://www.scopus.com/inward/record.url?scp=79957812065&partnerID=8YFLogxK
U2 - 10.1117/1.3540408
DO - 10.1117/1.3540408
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 21361704
AN - SCOPUS:79957812065
SN - 1083-3668
VL - 16
JO - Journal of Biomedical Optics
JF - Journal of Biomedical Optics
IS - 2
M1 - 027001
ER -